See more : China Investment Development Limited (0204.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Medical Properties Trust, Inc. (0JZZ.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medical Properties Trust, Inc., a leading company in the Real Estate – General industry within the Real Estate sector.
- Samart Corporation Public Company Limited (SAMART.BK) Income Statement Analysis – Financial Results
- Capital One Financial Corporation (COF) Income Statement Analysis – Financial Results
- Guardian Capital Group Limited (GRCGF) Income Statement Analysis – Financial Results
- Glory Flame Holdings Limited (8059.HK) Income Statement Analysis – Financial Results
- India Tourism Development Corporation Limited (ITDC.NS) Income Statement Analysis – Financial Results
Medical Properties Trust, Inc. (0JZZ.L)
About Medical Properties Trust, Inc.
Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospitals with 431 facilities and roughly 43,000 licensed beds in nine countries and across four continents on a pro forma basis. MPT's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 885.77M | 1.54B | 1.54B | 1.25B | 854.20M | 784.52M | 704.75M | 541.14M | 441.88M | 315.09M | 246.08M | 201.07M |
| Cost of Revenue | 41.57M | 378.67M | 360.35M | 289.14M | 176.31M | 142.32M | 130.92M | 97.09M | 73.66M | 28.24M | 21.94M | 6.90M |
| Gross Profit | 844.20M | 1.16B | 1.18B | 960.10M | 677.89M | 642.20M | 573.83M | 444.05M | 368.22M | 286.85M | 224.13M | 194.17M |
| Gross Profit Ratio | 95.31% | 75.46% | 76.67% | 76.86% | 79.36% | 81.86% | 81.42% | 82.06% | 83.33% | 91.04% | 91.08% | 96.57% |
| Research & Development | 0.00 | 0.62 | 0.47 | 0.37 | 0.44 | 1.30 | 0.42 | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 139.94M | 154.02M | 141.24M | 131.66M | 96.41M | 81.00M | 58.60M | 48.91M | 43.64M | 37.27M | 30.06M | 28.56M |
| Selling & Marketing | 5.65M | 6.48M | 4.39M | -131.66M | -96.41M | -81.00M | -58.60M | -48.91M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 145.59M | 0.58 | 0.42 | 0.34 | 0.44 | 1.29 | 0.41 | 0.41 | 43.64M | 37.27M | 30.06M | 28.56M |
| Other Expenses | 0.00 | -43.96M | -307.80M | -365.11M | -207.70M | 458.21M | -191.67M | -129.76M | -106.22M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 145.59M | 219.20M | 435.78M | 452.71M | 234.65M | 453.23M | 208.47M | 138.25M | 106.22M | 137.56M | 67.36M | 63.04M |
| Cost & Expenses | 187.16M | 264.90M | 474.88M | 477.60M | 258.64M | 462.46M | 243.93M | 162.43M | 179.88M | 165.80M | 89.30M | 69.94M |
| Interest Income | 0.00 | 355.04M | 367.39M | 328.73M | 237.83M | 223.27M | 176.95M | 159.60M | 120.88M | 98.16M | 66.75M | 58.24M |
| Interest Expense | 411.17M | 359.04M | 367.39M | 0.00 | 237.83M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 330.13M | 539.17M | 505.99M | 420.80M | 272.72M | 223.32M | 219.16M | 192.27M | 69.87M | 55.16M | 38.82M | 35.59M |
| EBITDA | 425.38M | 1.39B | 1.40B | 1.12B | 754.11M | 716.86M | 627.62M | 471.27M | 331.87M | 250.80M | 195.91M | 107.66M |
| EBITDA Ratio | 48.02% | 90.10% | 90.70% | 90.04% | 88.28% | 91.37% | 89.06% | 87.09% | 75.10% | 79.60% | 79.61% | 83.75% |
| Operating Income | 698.61M | 332.98M | 321.25M | 264.25M | 152.31M | 133.08M | 125.11M | 94.37M | 262.00M | 195.64M | 157.09M | 132.79M |
| Operating Income Ratio | 78.87% | 21.58% | 20.80% | 21.15% | 17.83% | 16.96% | 17.75% | 17.44% | 59.29% | 62.09% | 63.84% | 66.04% |
| Total Other Income/Expenses | -1.39B | 332.98M | 321.25M | 264.25M | 152.31M | 886.32M | 125.11M | 94.37M | -121.81M | -91.81M | -63.51M | -59.91M |
| Income Before Tax | -686.77M | 1.34B | 1.36B | 1.09B | 733.79M | 694.28M | 610.69M | 443.24M | 140.19M | 51.14M | 90.03M | 72.89M |
| Income Before Tax Ratio | -77.53% | 86.64% | 88.04% | 87.47% | 85.90% | 88.50% | 86.65% | 81.91% | 31.73% | 16.23% | 36.58% | 36.25% |
| Income Tax Expense | -130.68M | 1.00B | 1.04B | 828.44M | 581.48M | 561.20M | 485.58M | 348.87M | 1.50M | 340.00K | 726.00K | 19.00K |
| Net Income | -556.48M | 959.72M | 730.89M | 463.33M | 373.78M | 1.02B | 293.92M | 219.11M | 137.33M | 49.63M | 88.35M | 71.81M |
| Net Income Ratio | -62.82% | 62.20% | 47.32% | 37.09% | 43.76% | 129.94% | 41.71% | 40.49% | 31.08% | 15.75% | 35.90% | 35.71% |
| EPS | -0.93 | 55.90M | 73.95M | 31.06M | -2.62M | 367.67M | 358.44M | 254.78M | 0.63 | 0.29 | 0.58 | 0.54 |
| EPS Diluted | -0.93 | 901.00M | 653.86M | 429.35M | 372.38M | 368.59M | 358.44M | 254.78M | 0.63 | 0.29 | 0.58 | 0.54 |
| Weighted Avg Shares Out | 598.52M | 1.51 | 1.11 | 0.81 | 0.87 | 2.77 | 0.82 | 0.86 | 218.00M | 171.14M | 152.32M | 132.97M |
| Weighted Avg Shares Out (Dil) | 598.52M | 1.50 | 1.11 | 0.81 | 0.87 | 2.77 | 0.82 | 0.86 | 218.30M | 170.54M | 152.60M | 132.33M |
Source: https://incomestatements.info
Category: Stock Reports